Life Threatening Angioedema Due to Valsartan/Sacubitril With Previously Well-Tolerated ACE Inhibitor

Am J Ther. 2018 Jul/Aug;25(4):e508-e509. doi: 10.1097/MJT.0000000000000600.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aminobutyrates / adverse effects*
  • Angioedema / chemically induced*
  • Angioedema / complications
  • Angioedema / diagnosis
  • Angiotensin Receptor Antagonists / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Biphenyl Compounds
  • Drug Combinations
  • Heart Failure / drug therapy*
  • Humans
  • Intubation, Intratracheal
  • Male
  • Middle Aged
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / therapy*
  • Tetrazoles / adverse effects*
  • Valsartan

Substances

  • Aminobutyrates
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Biphenyl Compounds
  • Drug Combinations
  • Tetrazoles
  • Valsartan
  • sacubitril and valsartan sodium hydrate drug combination